Ten years on, EMA completes overhaul of biosimilar guidelines
This article was originally published in Scrip
Executive Summary
With the publication of a revised version of its guideline on non-clinical and clinical issues, the EMA has completed the updating of its trio of overarching guidelines on biosimilar products, nearly ten years after they were first published in 2005 and 2006.